- Record: found
- Abstract: not found
- Article: not found
A multi-country study of dengue vaccination strategies with Dengvaxia and a future vaccine candidate in three dengue-endemic countries: Vietnam, Thailand, and Colombia
April 2018
April 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The dengue vaccination era began when Dengvaxia (CYD-TDV) became available in 2016.
In addition, several second-generation vaccine candidates are currently in phase 3
trials, suggesting that a broader availability of dengue vaccines may be possible
in the near future. Advancing on the recent WHO-SAGE recommendations for the safe
and effective use of CYD-TDV at the regional level on average, this study investigates
the vaccination impacts and cost-effectiveness of CYD-TDV and of a hypothetical new
vaccine candidate (NVC) in a country-specific manner for three endemic countries:
Vietnam, Thailand, and Colombia.